JENA PINKOS: Open Payments
NPI 1467443739 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 50 payments from 11 companies in 2025. Trend: 2023 $1,104 · 2024 $684 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $261 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| ABBVIE INC. | 10 | $173 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| Lilly USA, LLC | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Dexcom, Inc. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: JARDIANCE, Ozempic, FARXIGA, UBRELVY, BREZTRI, SHINGRIX, SPRAVATO, Wegovy.
Industry payments across PA — which companies pay providers there.
